KRRO

Korro Bio, Inc. - Common Stock (KRRO)

About Korro Bio, Inc. - Common Stock (KRRO)

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Details

Daily high

$14.24

Daily low

$13.40

Price at open

$13.51

52 Week High

$98.00

52 Week Low

$10.29

Market cap

128.4M

Dividend yield

0.00%

Volume

99,678

Avg. volume

110,115

P/E ratio

-1.45

Korro Bio, Inc. - Common Stock News